NYSE:ZTSPharmaceuticals
What Zoetis (ZTS)'s Upbeat 2026 Outlook and Dividend Signal Means For Shareholders
In February 2026, Zoetis Inc. reported fourth-quarter 2025 sales of US$2,387 million and net income of US$603 million, with full-year 2025 sales of US$9.47 billion and net income of US$2.67 billion, alongside confirming a US$0.53 per-share second-quarter 2026 dividend.
The company also issued 2026 guidance calling for revenue of about US$9.83 billion to US$10.03 billion and reported diluted EPS of US$6.65 to US$6.75, highlighting expected contributions from international growth, new...